ArticleCancer biology & therapy2010

ITF2 is a target of CXCR4 in MDA-MB-231 breast cancer cells and is associated with reduced survival in estrogen receptor-negative breast cancer.

Hitesh Appaiah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.